*
*Cryptococcosis|42386007
*
*,
or
*
*cryptococcal disease|89912005|64572001
*
*,
is
a potentially fatal fungal disease.|399166001|3218000

It
is
caused|23981006|134198009
by one|421379005
of two species|420797005|69658003
;
_Cryptococcus neoformans_|42386007|67168003
and
_Cryptococcus gattii_.|243467007

These
were
all previously
thought|88952004
to
be
subspecies
of _C.

neoformans_,
but
have
now
been
identified|7882003
as distinct species.|69658003

Cryptococcosis|42386007
is
believed to
be
acquired|255396000
by inhalation|14910006|422237004
of the infectious propagule
from the environment.|276339004

Although
the exact nature|277302009
of the infectious propagule
is
unknown|261665006
,
the leading hypothesis|236874000
is
the basidiospore|2948002
created
through sexual|365952006
or
asexual reproduction.|263767004

Cryptococcosis|42386007
is
a defining opportunistic infection|61274003
for AIDS.|62479008

Other conditions|74964007|260905004
which
pose
an increased risk|35105006|30207005|260366006|30207005
include|55919000
certain lymphomas|17162000|118600007
(e.g.|258795003

Hodgkin's lymphoma,|118606001
sarcoidosis,|31541009
liver cirrhosis|19943007
and
patients|116154003
on long-term corticosteroid therapy.|297279009

Distribution|255464007
is
worldwide
in soil.|415555003

The prevalence
of cryptococcosis|42386007
has
been
increasing|260369004
over the past 20 years|410513005|258707000
for many reasons,|410666004
including|55919000
the increase|260366006
in incidence
of AIDS|62479008
and
the expanded use|70955005|277889008|70955005|419385000
of immunosuppressive drugs.|372823004|410942007

In humans,|278412004
_C.

neoformans_
causes|134198009
three types|421291004|261664005
of infections
:

Cryptococcal meningitis|14232007
(infection
of the meninges,|363824000
the tissue|85756007
covering|255334000
the brain|12738006|258335003
)
is
believed to
result|394617004
from dissemination|65709003
of the fungus|414561005
from
either
an observed
or
unappreciated pulmonary infection.|128601007

Often there|70232002
is
also silent dissemination|263872000|65709003
throughout the brain|12738006|258335003
when
meningitis|7180009
is
present.|52101004|246105001

_Cryptococcus gattii_|243467007
causes|134198009
infections
in immunocompetent people|35194002|125676002
(
those
having
a functioning immune system,|246464006|116003000
but
_C.

neoformans v.

grubii_,
and
_v.

neoformans_ usually only
cause|23981006|134198009
clinically evident infections|18669006
in persons|125676002
who
have
some form|246176004
of defect|6920004
in their immune systems|116003000
(immunocompromised persons|370391006|125676002
).

People|125676002
who
have
defects|6920004
in their cell-mediated immunity,|4421005|73510009|58915005|362837007|73510009|58915005
for example,
people|125676002
with AIDS,|62479008
are
especially susceptible|131196009
to disseminated cryptococcosis.|240725003

Cryptococcosis|42386007
is
often fatal, even|70232002|399166001
if
treated.|28995006

The 10-week survival averages|258705008|259038000
near 70%
with optimal therapy.|276239002

Although
the most common presentation|4757001|72906007|246105001
of cryptococcosis|42386007
is
of _C.

neoformans_ infection
in an immunocompromised person|370391006|125676002
(
such as persons|125676002
living|224130005|419749002
with AIDS|62479008
)
,
the _C.

gattii_
is
being
increasingly
recognised
as a pathogen|264418008
in presumptively immunocompetent hosts,|35194002
especially
in Canada|223686002
and
Australia.|223621005

This
may
be
due to rare exposure|84638005|71677004|84638005|24932003|103356009|71677004|103356009|24932003
and
high pathogenicity,|75540009|264418008|371879000|264418008
or
to
unrecognised
isolated defects|46651001|6920004
in immunity,|58915005
specific|69658003
for this organism.|410653004

Dependent|371154000
on the infectious syndrome,
symptoms
include|55919000
fever,|386661006
fatigue,|84229001
chest pain,|29857009
dry cough,|409596002
swelling|423666004|442672001
of abdomen,|277112006|52731004|302553009
headache,|25064002
blurred vision|246636008
and
confusion.[2]|286933003

Detection
of cryptococcal antigen|103094002
(capsular material|11070000|260769002
)
by culture|252398009|61594008
of CSF,
sputum|45710003
and
urine|78014005
provides
definitive diagnosis.|261002007|439401001|261002007

Blood cultures|30088009
may
be
positive|258758003|10828004
in heavy infections.|410712002

India ink|406972004
of the CSF
is
a traditional microscopic method|263901007|84496004|260686004|263901007|84496004|272394005
of diagnosis,|439401001
although
the sensitivity|35209006|365705006
is
poor|11403006|255351007
in early infection,|264499004
and
may
miss
up to
>
=20%
of patients|116154003
with culture-positive cryptococcal meningitis.|252398009|258758003|14232007|252398009|10828004|14232007|61594008|258758003|14232007|61594008|10828004|14232007

Cryptococcosis|42386007
can
rarely|103356009
occur|272120004
in the immunocompetent person|35194002|125676002
without HIV,|19030005|86406008|402916007
when
it usually
goes
undiagnosed.

Less
than 250 cases|398241000|413769002
in all
are
reported|229059009|223458004
in the medical literature,|74188005
the majority
diagnosed postmortem.[4]|439401001|168461002

Treatment options|276239002|416118004
in non-AIDS patients|62479008|116154003
who
have
reduced|260400001
immune-system function|246333005|116003000|246464006
is
not well studied.|20572008|110465008|20572008|224699009

Intravenous Amphotericin B|77703004|255560000|77703004
combined|89780004
with oral flucytosine|260548002|387155003
may
be
effective.|255403003|254648000

Every attempt
should
be
made
to
reduce|260400001
the amount|107651007
of immunosuppressive medication|372823004|410942007
until the infection
is
resolved.

Persons|125676002
living|224130005|419749002
with AIDS often|62479008|70232002
have
a greater burden|263768009
of disease|64572001
and
higher mortality|75540009|409651001|371879000|409651001
(30-70%
at 10-weeks|258705008
)
,
but
recommended therapy|276239002
is
with Amphotericin B|77703004
(0.7-1.0 mg/kg/day|258835005|223574006|258835005|258683005|258703001|259032004
)
and
flucytosine.|387155003

Where flucytosine|387155003
(5FC|387155003
)
is
not available, fluconazole 800-1200mg/day|103328004|387174006|258703001|103328004|387174006|259032004
should
be
used|394850002
adjunctively
with amphotericin.|372643008

Amphotericin-based induction therapy|372643008|16404004|276239002|372643008|418836005|16404004|276239002
has
much greater microbiologic activity|242762006|263768009|19851009|48761009|242762006|263768009|19851009|55561003|242762006|263768009|19851009|258745004|242762006|263768009|19851009|257733005|4757001|263768009|19851009|48761009|4757001|263768009|19851009|55561003|4757001|263768009|19851009|258745004|4757001|263768009|19851009|257733005
than fluconazole monotherapy|387174006
with 30% better survival|3442003
at 10-weeks.|258705008

Based|418836005
on a systematic review|415300000
of existing data,
the most cost-effective induction treatment|4757001|255403003|16404004|276239002|4757001|255403003|16404004|416118004|4757001|254648000|16404004|276239002|4757001|254648000|16404004|416118004
in resource-limited settings|255469002
appears
to
be
one week|421379005|258705008|421379005|259038000
of amphotericin B 1mg/kg/day|77703004|223574006|258703001|77703004|223574006|259032004|77703004|258683005|258703001|77703004|258683005|259032004
coupled
with high dose fluconazole 1200mg/day.|261829003|387174006|258703001|261829003|387174006|259032004

After initial treatment|884001|276239002|884001|416118004|232714002|276239002|232714002|416118004
as above, oral fluconazole|261183002|260548002|387174006
can
be
used.|394850002

The decision
on
when
to
start|255395001
treatment|276239002|416118004
for HIV|19030005|86406008|402916007
is
not yet
settled|128719006
,
although
one small, under-powered trial|421379005|255507004|110465008
(
when
restricting|263856008
to a "
per protocol analysis"|258049002|272389005
)
suggested
that delaying
the start|255395001
of treatment|276239002|416118004
for several weeks|261028005|258705008
may
be
beneficial
in avoiding deaths|419620001|268923008
from Immune reconstitution inflammatory syndrome|426202004
(IRIS|41296002|27527003|181164000
).

A larger multisite trial,|255509001|110465008|263768009|110465008
the Cryptococcal Optimal ART Timing (COAT) Trial,|89912005|246512002|110465008
will
be
completed|255594003
in spring 2013.

Cryptococcosis|42386007
is
a very subacute infection|260358002|17098006
with a prolonged subclinical phase lasting weeks|255224006|74314007|21191007|258705008
to months|258706009
in persons|125676002
with HIV/AIDS|19030005|62479008|86406008|62479008|402916007|62479008
before the onset|77374008
of symptomatic meningitis.|264931009|7180009

In Sub-Saharan Africa,|409988000
the prevalence rates
of detectable cryptococcal antigen|103094002
in perpheral blood|87612001|119273009
is
often 4-12%|70232002
in persons|125676002
with CD4
counts|258734002
lower|261122009
than 100 cells/mcL.|4421005|443487006|4421005|258774008|4421005|420167005

Cryptococcal antigen screen|103094002|20135006|103094002|103094002|360156006
and
preemptive treatment|276239002|416118004
with fluconazole|387174006
is
cost
saving
to the health care system|263775005|246333005
by avoiding cryptococcal meningitis.|14232007

The World Health Organization|263775005|21139007
recommends
cryptococcal antigen screening|103094002|20135006
in HIV-infected persons|19030005|125676002|86406008|125676002|402916007|125676002
entering|417985001
care
with CD4
<100 cells/?L.|258877005

This undetected subclinical cryptococcal|74314007|89912005
(
if
not preemptively
treated|28995006
with anti-fungal therapy|414561005|276239002
)
will
often|70232002
go
on to
develop
cryptococcal meningitis,|14232007
despite
receiving HIV therapy.|19030005|276239002|86406008|276239002|402916007|276239002

[8] Cryptococcosis|42386007
accounts
for 20-25%|419607004
of the mortality|409651001
after initiating HIV therapy|19030005|276239002|86406008|276239002|402916007|276239002
in Africa.|223498002

The immune reconstitution inflammatory syndrome (IRIS)|426202004
has
been
described
in immunocompetent hosts|35194002
who
have
meningitis|7180009
caused|23981006|134198009
by _C.

gattii_
and
_C.

grubii_.

Several weeks|261028005|258705008
or
even months|258706009
into appropriate treatment,|276239002|416118004
there
is
a sudden onset deterioration|385315009|255363002
with worsening meningitis symptoms|230993007|7180009|231877006|7180009
and
progression|246453008|246450006
or
development|278923009
of new neurological symptoms.|7147002|267070008

IRIS|41296002|27527003|181164000
is
however much more common|72906007
in immunocompromised hosts.|370391006

Magnetic resonance imaging|113091000
shows
increase|260366006
in the size|277049003
of brain lesions,|301766008
and
CSF abnormalities|276654001
(white cell count,|413773004|118218001|185984009|118218001|371251000|118218001
protein,|88878007
glucose|67079006|72191006
)
increase.|260366006

CSF culture|275855006
is
sterile,|261029002|15296000
and
there
is
no increase|260366006
in CSF cryptococcal antigen titre.|103094002|118590008

The increasing inflammation|260369004|257552002
can
cause|23981006|134198009
brain injury|2470005
or
be
fatal.[11][12][13]|399166001

The mechanism|257544000
behind IRIS|41296002|27527003|181164000
in cryptococcal meningitis|14232007
is
primarily immunologic.|37523008

With reversal
of immunosuppression,|86553008|38013005
there
is
paradoxical increased inflammation|27699000|35105006|257552002|27699000|260366006|257552002
as the recovering immune system|74822006|116003000
recognises
the fungus.|414561005

In severe IRIS cases,|24484000|41296002|398241000|24484000|41296002|413769002|24484000|27527003|398241000|24484000|27527003|413769002|24484000|181164000|398241000|24484000|181164000|413769002
treatment|276239002|416118004
with systemic corticosteroids|31099001|79440004
has
been
utilized.

Cryptococcosis|42386007
is
also
seen
in cats|448169003|388618001
and
occasionally dogs.|448771007

It
is
the most common deep fungal disease|4757001|72906007|131197000|3218000
in cats,|448169003|388618001
usually
leading|236874000
to chronic infection|177010002
of the nose|260540009|181195007
and
sinuses,|2095001
and
skin ulcers.|46742003

Cats|448169003|388618001
may
develop
a bump
over the bridge|277035007
of the nose|260540009|181195007
from local tissue inflammation.|255470001|85756007|257552002

It
can
be
associated|47429007
with FeLV infection|40480006
in cats.|448169003|388618001

Cryptococcosis|42386007
is
most common|4757001|72906007
in dogs|448771007
and
cats|448169003|388618001
but
cattle,
sheep,|388254009|255392003
goats,|125097000|388249000
horses,|35354009
wild animals|262290003|387961004
and
birds|387972009
can
also
be
infected.

Soil,|415555003
fowl manure
and
pigeon droppings|260155006
are
among the sources|260753009
of infection.[14][15]

M
:
MYC

fung,|414561005
clas|258391009

fung|414561005

drug|410942007
(fung|414561005

